Global Stroke Diagnostic and Therapeutic Market Size By Type(Diagnostics, Therapeutics), By Application(Ischemic Stroke, Hemorrhagic Stroke), By Geographic Scope And Forecast
Global Stroke Diagnostic and Therapeutic Market Size By Type(Diagnostics, Therapeutics), By Application(Ischemic Stroke, Hemorrhagic Stroke), By Geographic Scope And Forecast
Published Date: July - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format
Global Stroke Diagnostic and Therapeutic Market Size By Type(Diagnostics, Therapeutics), By Application(Ischemic Stroke, Hemorrhagic Stroke), By Geographic Scope And Forecast
Stroke Diagnostic and Therapeutic Market Size and Forecast
Stroke Diagnostic and Therapeutic Market size was valued at USD 35.15 Billion in 2023 and is projected to reach USD 64.59 Billion by 2031, growing at a CAGR of 7.90%during the forecast period 2024-2031.
Global Stroke Diagnostic and Therapeutic Market Drivers
The market drivers for the Stroke Diagnostic and Therapeutic Market can be influenced by various factors. These may include
Stroke Prevalence One important factor is the prevalence of strokes globally. The incidence of strokes rises with the aging of the world population and the contribution of risk factors such obesity, diabetes, and hypertension from lifestyle choices.
Technological Developments The efficiency and accuracy of stroke diagnosis have increased thanks to developments in medical imaging technology including MRIs, CT scans, and ultrasounds. The market is also growing as a result of advancements in neurointerventional devices and minimally invasive surgical methods.
Government Funding and programs Funding for stroke research and government programs to increase stroke awareness, prevention, and treatment are key factors driving market expansion. These programs frequently result in improved access to cutting-edge stroke care services and a larger hospital infrastructure.
Growing Aging Population As people age, they become more vulnerable to strokes, which increases the need for stroke prevention and treatment options. The need for specialized stroke treatment, including rehabilitation services, is particularly high among the older population, which is propelling market expansion.
Growing Healthcare Expenditure The adoption of cutting-edge stroke diagnostic and treatment options is facilitated by rising healthcare spending worldwide, especially in developed economies. Stroke therapy alternatives are becoming more accessible as a result of emerging markets’ increased healthcare coverage.
Programs for Raising Public Awareness and Education These initiatives raise patient knowledge and demand for diagnostic and treatment options by educating the public about stroke symptoms, risk factors, and the value of early intervention.
Emerging Markets In emerging markets, the market is growing due to factors such rising disposable income, better healthcare facilities, and rapid urbanization. The need for improved access to healthcare services and cutting-edge medical technologies is growing in these areas.
Clinical Trials and Research By introducing new goods and treatment modalities, ongoing clinical trials and research aim to produce novel medications, efficient rehabilitation procedures, and revolutionary stroke diagnostic instruments all contribute to market expansion.
Initiatives for Stroke Prevention By lowering the overall number of stroke cases, efforts to prevent strokes by lifestyle changes—such as encouraging a healthy diet, frequent exercise, and programs to quit smoking—indirectly benefit the market.
What's inside a industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
Global Stroke Diagnostic and Therapeutic Market Restraints
Several factors can act as restraints or challenges for the Stroke Diagnostic and Therapeutic Market. These may include
High Cost of Diagnostic and Therapeutic Procedures Because advanced stroke diagnostic methods and treatments can be costly, access to them may be restricted for individuals who cannot afford them or whose insurance does not cover them.
Restricted Access to Medical Facilities Patients may not obtain prompt diagnosis or treatment in areas with restricted access to medical facilities or specialists, which could result in worse outcomes.
Strict Regulations New medicinal medications or diagnostic tools may face delays in entering the market due to strict regulations and approval procedures, which can impede innovation and growth.
Lack of Education and Awareness A lot of people are unaware of the signs of a stroke or the significance of prompt intervention. A worse prognosis and a delay in therapy may arise from this ignorance.
Technological Constraints Accurate diagnosis and successful treatment of strokes may be hampered by technological constraints in therapeutic devices or diagnostic imaging.
Risk of Complications Patients or healthcare professionals may be discouraged from choosing certain stroke diagnostic or treatment measures because of the potential for complications.
Limited Effectiveness of Current Therapies Despite improvements in the management of strokes, some patients may not benefit from the treatments now available. This has prompted continuous research and development initiatives to increase treatment efficacy.
Ageing Population As people age, their risk of stroke increases. This could lead to a rise in the need for stroke detection and treatment, but it also creates problems with comorbidities and healthcare resources.
Healthcare Infrastructure In some areas, especially in rural or poor areas, a lack of proper healthcare infrastructure can restrict access to facilities for stroke diagnosis and treatment.
Insurance Coverage For certain patients, receiving the appropriate care may be hampered by limited or insufficient insurance coverage for stroke-related diagnostic procedures and therapies.
Global Stroke Diagnostic and Therapeutic Market Segmentation Analysis
The Global Stroke Diagnostic and Therapeutic Market is Segmented on the basis of Diagnostic Imaging Modalities, Diagnostic Blood Tests, Therapeutic Interventions, Stroke Prevention Strategies  and Geography.
Stroke Diagnostic and Therapeutic Market, By Diagnostic Imaging Modalities
Computed Tomography (CT) Scans Fast and widely available imaging method to detect hemorrhagic strokes.
Magnetic Resonance Imaging (MRI) Provides detailed images of brain tissue, useful for identifying ischemic strokes.
Doppler Ultrasound Assesses blood flow in the brain’s arteries, aiding in diagnosing and monitoring strokes.
Stroke Diagnostic and Therapeutic Market, By Diagnostic Blood Tests
Biomarker Analysis Blood tests measure biomarkers like brain natriuretic peptide (BNP) and D-dimer levels, aiding in stroke diagnosis and risk assessment.
Genetic Testing Identifies genetic predispositions to stroke and helps tailor treatment plans.
Stroke Diagnostic and Therapeutic Market, By Therapeutic Interventions
Thrombolytic Therapy Administers clot-dissolving drugs like tissue plasminogen activator (tPA) to dissolve blood clots causing ischemic strokes.
Mechanical Thrombectomy Removes large clots from blood vessels using specialized devices, improving blood flow and reducing brain damage.
Neuroprotective Agents Medications aimed at minimizing brain damage during and after a stroke, preserving neurological function.
Rehabilitation Therapies Physical, occupational, and speech therapy programs help stroke survivors regain lost functions and improve quality of life.
Stroke Diagnostic and Therapeutic Market, By Stroke Prevention Strategies
Medication Management Anticoagulants, antiplatelet agents, and blood pressure medications help reduce the risk of recurrent strokes.
Lifestyle Modifications Diet, exercise, smoking cessation, and stress management play crucial roles in stroke prevention.
Surgical Interventions Carotid endarterectomy or angioplasty with stenting may be performed to treat narrowed carotid arteries and reduce stroke risk.
Stroke Diagnostic and Therapeutic Market, By Geography
North AmericaMarket conditions and demand in the United States, Canada, and Mexico.
EuropeAnalysis of the Stroke Diagnostic and Therapeutic Market in European countries.
Asia-PacificFocusing on countries like China, India, Japan, South Korea, and others.
Middle East and AfricaExamining market dynamics in the Middle East and African regions.
Latin AmericaCovering market trends and developments in countries across Latin America.
Key Players
The major players in the Stroke Diagnostic and Therapeutics Market are Cordis Corporation, Neural Analytics, Koninklijke Philips N.V., Cerebrotech Medical Systems, Inc., Medtronic plc., GE Healthcare, Boston Scientific Corporation, Medfield Diagnostics, Samsung Neurologica, Siemens AG, Stryker, Â Abbott Laboratories, Johnson & Johnson, Penumbra, Inc., Genentech, Inc.
These companies are focusing on enhancing their research and development departments so that more new therapeutic products and services can be developed in the global Stroke Diagnostic and Therapeutic Market.
Report Scope
REPORT ATTRIBUTES
DETAILS
STUDY PERIOD
2020-2030
BASE YEAR
2023
FORECAST PERIOD
2024-2030
HISTORICAL PERIOD
2020-2022
UNIT
Value (USD Billion)
KEY COMPANIES PROFILED
Cordis Corporation, Neural Analytics, Koninklijke Philips N.V., Cerebrotech Medical Systems, Inc., Medtronic plc., GE Healthcare, Boston Scientific Corporation, Medfield Diagnostics, Samsung Neurologica, Siemens AG, Stryker.
SEGMENTS COVERED
By Diagnostic Imaging Modalities, By Diagnostic Blood Tests, By Therapeutic Interventions, By Stroke Prevention Strategies  and By Geography
CUSTOMIZATION SCOPE
Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the Market based on segmentation involving both economic as well as non-economic factors• Provision of Market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the Market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the Market within each region• Competitive landscape which incorporates the Market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major Market players• The current as well as the future Market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the Market of various perspectives through Porter’s five forces analysis• Provides insight into the Market through Value Chain• Market dynamics scenario, along with growth opportunities of the Market in the years to come• 6-month post-sales analyst support
Customization of the Report
• In case of any  please connect with our sales team, who will ensure that your requirements are met.
Table of Content
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
List Tables Figures
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
For a single, multi and corporate client license, the report will be available in PDF format.
Sample report would be given you in excel format. For more questions please contact:
Sample Report for Global Stroke Diagnostic and Therapeutic Market Size By Type(Diagnostics, Therapeutics), By Application(Ischemic Stroke, Hemorrhagic Stroke), By Geographic Scope And Forecast
